首页> 外文OA文献 >Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?
【2h】

Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?

机译:T3 / T4喉鳞状细胞癌的原发非手术治疗前的气道干预对肿瘤或功能结局有影响吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

QUESTIONS UNDER STUDY: Even today, some patients with laryngeal cancer present with airway obstruction necessitating an intervention in the form of either a tracheostomy or transoral laser debulking (TOL). Controversy exists as to whether such an intervention is a risk factor for poor oncological or functional outcome in patients who then undergo primary (chemo)radiotherapy.\udMETHODS: Retrospective chart review of all patients undergoing primary curative nonsurgical treatment for T3/T4 laryngeal squamous cell cancer at the University Hospital Zurich between 1981 and 2011.\udRESULTS: A total of 29/114 patients had an airway intervention before initiation of (chemo)radiotherapy (21/29 tracheostomies, 8/29 TOL). Kaplan-Meier analysis showed no statistical difference in oncological outcomes between the groups with and without intervention (5 year overall survival: 52% vs 70%, disease specific survival: 73% vs 79%, recurrence free survival: 53% vs 63%). In functional terms, we report an overall functional larynx rate of 60%.\udCONCLUSIONS: Airway intervention was not found to be a risk factor for poor oncological or functional outcome in this patient group.
机译:研究中的问题:即使在今天,一些喉癌患者仍存在气道阻塞,需要采取气管切开术或经口激光减瘤(TOL)的形式进行干预。存在争议,在于这种干预是否是随后接受原发(化学)放疗的患者肿瘤学或功能预后不良的危险因素。\ ud方法:回顾性图表回顾了所有接受原发性非手术治疗T3 / T4喉鳞状细胞癌的患者。结果:1981年至2011年间,苏黎世大学医院发生了癌症。\ ud结果:总共29/114例患者在开始(化学)放疗之前接受了气道干预(21/29气管切开术,8/29 TOL)。 Kaplan-Meier分析显示,有无干预组之间的肿瘤结局无统计学差异(5年总生存期:52%vs 70%,疾病特异性生存期:73%vs 79%,无复发生存期:53%vs 63%) 。就功能而言,我们报告喉总功能率为60%。\ ud结论:在该患者组中,未发现气道干预是导致肿瘤或功能预后不良的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号